Status:
RECRUITING
Risk Factors and Outcomes in Coronary Chronic Total Occlusion
Lead Sponsor:
Ruijin Hospital
Conditions:
Chronic Total Occlusion
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to assess the risk factors and evaluate the long-term outcomes of patients with coronary chronic total occlusion (CTO) treated with percutaneous coronary intervention or medical treatm...
Detailed Description
Coronary artery disease (CAD) is still one of the major contributors to global mortality. CTO is a special lesion type of CAD, defined as complete occlusion of at least one major epicardial coronary a...
Eligibility Criteria
Inclusion
- Age ≥18 years; Patients with angina or silent ischemia and documented ischemia; Patients with CTO ≥ 3months
Exclusion
- eGFR\<15mL/(min·1.73m2); Chronic heart failure with NYHA grade ≥3; Had a history of coronary artery bypass grafting; Had received a percutaneous coronary intervention within the prior 3 months; Malignant tumor or immune system disorders; Pulmonary heart disease
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06137521
Start Date
January 1 2010
End Date
March 1 2027
Last Update
November 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China